Sumatriptan and Sennosides drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Sumatriptan (sumatriptan succinate) and Sennosides (senna). Common drug interactions include blood pressure increased among females and anxiety among males.
The phase IV clinical study analyzes what interactions people have when they take Sumatriptan and Sennosides. It is created by eHealthMe based on reports of 49 people who take the same drugs from the FDA, and is updated regularly.
What is Sumatriptan?
Sumatriptan has active ingredients of sumatriptan succinate. It is often used in migraine. eHealthMe is studying from 18,159 Sumatriptan users. Check the latest studies of Sumatriptan.
What is Sennosides?
Sennosides has active ingredients of senna. It is often used in constipation. eHealthMe is studying from 8,247 Sennosides users. Check the latest studies of Sennosides.
49 people who take Sumatriptan and Sennosides together, and have interactions are studied.

What are the common drug interactions of Sumatriptan and Sennosides, by gender? *:
female:
- Blood pressure increased
- Cardiac failure congestive
- Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
- Clostridium test positive
- Conjunctivitis (pink eye)
- Cystic fibrosis (disease of the secretary glands)
- Death
- Dehydration (dryness resulting from the removal of water)
- Dermatitis allergic (inflammation of the skin due allergic reaction)
- Headache (pain in head)
male:
- Anxiety
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Skin ulcer
- Cardiac failure congestive
- Osteopenia (a condition where bone mineral density is lower than normal)
- Abdominal distension
- Asthenia (weakness)
- Back pain
- Blood creatinine increased
- Bone density decreased
What are the common drug interactions of Sumatriptan and Sennosides, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Anxiety
- Emergency care
- Metabolic encephalopathy (disorder or disease of the brain due to the body's disability to use energy)
- Suicidal ideation
- Therapeutic response unexpected
20-29:
n/a
30-39:
- Febrile neutropenia (fever with reduced white blood cells)
- Pancreatitis acute (sudden inflammation of pancreas)
40-49:
- Iron deficiency
- Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
- Neuroleptic malignant syndrome (a life-threatening neurological disorder most often caused by an adverse reaction to neuroleptic or antipsychotic agents)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Skin ulcer
- Diarrhoea
- Nausea (feeling of having an urge to vomit)
- Vomiting
50-59:
- Anxiety
- Depression
- Dizziness
- Fatigue (feeling of tiredness)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Emotional distress
- Osteopenia (a condition where bone mineral density is lower than normal)
- Osteoporosis (bones weak and more likely to break)
- Pain
- Renal impairment (severely reduced kidney function)
60+:
- Cardiac failure congestive
- Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
- Renal impairment (severely reduced kidney function)
- Renal injury (kidney injury)
- Acute myeloid leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts)
- Anhedonia (inability to experience pleasure from activities usually found enjoyable)
- Anxiety
- Bacterial test positive
- Blood creatinine increased
- Bone density decreased
What are the existing conditions these people have? *
- Pain: 11 people, 22.45%
- Headache (pain in head): 9 people, 18.37%
- Dyspnea (difficult or laboured breathing): 9 people, 18.37%
- Nausea (feeling of having an urge to vomit): 8 people, 16.33%
- Stress And Anxiety: 7 people, 14.29%
- Nausea And Vomiting: 7 people, 14.29%
- Multiple Myeloma (cancer of the plasma cells): 6 people, 12.24%
- Cough: 6 people, 12.24%
- Atrial Fibrillation/flutter (atrial fibrillation and flutter are abnormal heart rhythms in which the atria, or upper chambers of the heart, are out of sync with the ventricles): 5 people, 10.20%
- Fever: 5 people, 10.20%
* Approximation only. Some reports may have incomplete information.
Do you take Sumatriptan and Sennosides?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Sumatriptan (18,159 reports)
- Sennosides (8,247 reports)
Browse all drug interactions of Sumatriptan and Sennosides:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Sumatriptan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Sennosides:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sumatriptan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Sennosides and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on sumatriptan succinate and senna (the active ingredients of Sumatriptan and Sennosides, respectively), and Sumatriptan and Sennosides (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Memantine Hydrochloride and Lipitor - 9 seconds ago
- Could Levemir cause Type 2 Diabetes? - 14 seconds ago
- Could Levemir cause Diabetes Mellitus Non-Insulin-Dependent? - 15 seconds ago
- Razadyne vs. Dalmane, side effect and effectiveness comparison - 23 seconds ago
- Breathing - Slowed Or Stopped and Muscle Atrophy - 32 seconds ago
- Could Incivek cause Cough? - 39 seconds ago
- Could B6 cause Burning Sensation? - 41 seconds ago
- Could Alprazolam cause Traumatic Lung Injury? - 46 seconds ago
- Drug interactions of Nucala and Hctz - 53 seconds ago
- Could Clonidine cause Restless Leg Syndrome? - 55 seconds ago